SCHEMBL8287481

SCHEMBL8287481

CN(C)C(=O)CNc1cc2c(cn1)c(=O)cc(Nc1ccccc1)n2-c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAT2A P31153 4/20 0.49
MAPK1 P28482 4/20 0.39
ADORA3 P0DMS8 3/20 0.38
ADORA1 P30542 3/20 0.38
KDM4E B2RXH2 1/20 0.35
HTT P42858 1/20 0.35
CSF1R P07333 1/20 0.34
SYK P43405 1/20 0.34
TNK2 Q07912 1/20 0.34
GSK3B P49841 1/20 0.34
PIK3CA P42336 1/20 0.34
PRKDC P78527 1/20 0.34
EGFR P00533 1/20 0.34
TSPO P30536 1/20 0.34
GAA P10253 2/20 0.33
GFER P55789 1/20 0.33
HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8287514 0.89 EGFR (0.42) MAT2AADORA3ADORA1GSK3BPIK3CA
SCHEMBL8287565 0.87 HTT (0.41) MAT2AADORA3ADORA1KDM4EHTT
SCHEMBL8287483 0.86 ADORA3 (0.45) MAT2AADORA3ADORA1KDM4EEGFR
SCHEMBL8287923 0.83 MAT2A (0.41) MAT2AMAPK1CSF1RTNK2GSK3B
SCHEMBL8362929 0.82 PIK3CA (0.44) MAT2AMAPK1ADORA3ADORA1GSK3B
SCHEMBL8287236 0.82 MAT2A (0.40) MAT2AMAPK1KDM4ETNK2EGFR
SCHEMBL8362927 0.82 MAT2A (0.44) MAT2AADORA3ADORA1KDM4EHTT
SCHEMBL8287591 0.81 LMNA (0.42) MAPK1KDM4EHTTTNK2GAA
SCHEMBL8286470 0.80 KCNH3 (0.40) MAPK1KDM4EGSK3BPIK3CAPRKDC
SCHEMBL8286451 0.80 RAB9A (0.36) MAT2AADORA3ADORA1KDM4EGSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed